6 insiders reported 91 Form 4 transactions for IOVANCE BIOTHERAPEUTICS, INC. (IOVA) over the past 18 months (most recent 2026-06-09). Recent activity: Vogt Frederick G (Interim CEO & General Counsel) Buy 15,625 shares, Vogt Frederick G (Interim CEO & General Counsel) Sell 6,638 shares, GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) Buy 7,813 shares, Puri Raj K. (Chief Regulatory Officer) Buy 9,766 shares, Puri Raj K. (Chief Regulatory Officer) Sell 3,843 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Vogt Frederick G | Interim CEO & General Counsel | Buy | 15,625 | $0 |
| 2026-06-09 | Vogt Frederick G | Interim CEO & General Counsel | Sell | 6,638 | $28,079 |
| 2026-06-09 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Buy | 7,813 | $0 |
| 2026-06-09 | Puri Raj K. | Chief Regulatory Officer | Buy | 9,766 | $0 |
| 2026-06-09 | Puri Raj K. | Chief Regulatory Officer | Sell | 3,843 | $16,256 |
| 2026-06-09 | BILINSKY IGOR | Chief Operating Officer | Sell | 3,976 | $16,818 |
| 2026-06-09 | BILINSKY IGOR | Chief Operating Officer | Buy | 7,813 | $0 |
| 2026-06-09 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Sell | 3,976 | $16,818 |
| 2026-06-03 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Sell | 4,473 | $17,713 |
| 2026-06-03 | BILINSKY IGOR | Chief Operating Officer | Buy | 8,790 | $0 |
| 2026-06-03 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Buy | 8,790 | $0 |
| 2026-06-03 | Puri Raj K. | Chief Regulatory Officer | Buy | 5,469 | $0 |
| 2026-06-03 | Vogt Frederick G | Interim CEO & General Counsel | Buy | 41,668 | $0 |
| 2026-06-03 | Puri Raj K. | Chief Regulatory Officer | Sell | 2,508 | $9,932 |
| 2026-06-03 | BILINSKY IGOR | Chief Operating Officer | Sell | 4,473 | $17,713 |
| 2026-06-03 | Vogt Frederick G | Interim CEO & General Counsel | Sell | 17,701 | $70,096 |
| 2026-05-13 | Kirby Daniel Gordon | Chief Commercial Officer | Buy | 10,000 | $0 |
| 2026-05-13 | Kirby Daniel Gordon | Chief Commercial Officer | Sell | 2,435 | $9,010 |
| 2026-03-06 | BILINSKY IGOR | Chief Operating Officer | Buy | 31,246 | $0 |
| 2026-03-06 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Buy | 31,246 | $0 |
| 2026-03-06 | Vogt Frederick G | Interim CEO & General Counsel | Buy | 62,493 | $0 |
| 2026-03-06 | Vogt Frederick G | Interim CEO & General Counsel | Sell | 26,755 | $122,538 |
| 2026-03-06 | Puri Raj K. | Chief Regulatory Officer | Buy | 39,059 | $0 |
| 2026-03-06 | Puri Raj K. | Chief Regulatory Officer | Sell | 18,360 | $84,089 |
| 2026-03-06 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Sell | 16,520 | $75,662 |
Source: SEC Form 4 filings · as of 2026-06-09